Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report

被引:36
作者
Ceruti, Michele [1 ]
Rodi, Giuseppe
Stella, Giulia M. [1 ]
Adami, Andrea [2 ]
Bolongaro, Antonia
Baritussio, Aldo [3 ]
Pozzi, Ernesto [1 ]
Luisetti, Maurizio [1 ]
机构
[1] Univ Pavia, Fdn IRRCS, Clin Malattie Apparato Respiratorio, I-27100 Pavia, Italy
[2] Univ Pavia, Fdn IRCCS Policlin San Matteo, Serv Anestesia & Rianimaz, I-27100 Pavia, Italy
[3] Univ Padua, Med Clin 1, Dipartimento Sci Med & Chirurgiche, I-35100 Padua, Italy
来源
ORPHANET JOURNAL OF RARE DISEASES | 2007年 / 2卷
关键词
CHOLESTEROL GRANULOMAS; PEDIATRIC-PATIENTS; DISEASE; SLC7A7;
D O I
10.1186/1750-1172-2-14
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Pulmonary alveolar proteinosis (PAP) is a rare disease characterised by accumulation of lipoproteinaceous material within alveoli, occurring in three clinically distinct forms: congenital, acquired and secondary. Among the latter, lysinuric protein intolerance (LPI) is a rare genetic disorder caused by defective transport of cationic amino acids. Whole Lung Lavage (WLL) is currently the gold standard therapy for severe cases of PAP. Case presentation: We describe the case of an Italian boy affected by LPI who, by the age of 10, developed digital clubbing and, by the age of 16, a mild restrictive functional impairment associated with a high-resolution computed tomography (HRCT) pattern consistent with pulmonary alveolar proteinosis. After careful assessment, he underwent WLL. Conclusion: Two years after WLL, the patient has no clinical, radiological or functional evidence of pulmonary disease recurrence, thus suggesting that WLL may be helpful in the treatment of PAP secondary to LPI.
引用
收藏
页数:7
相关论文
共 26 条
[1]   Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis [J].
Beccaria, M ;
Luisetti, M ;
Rodi, G ;
Corsico, A ;
Zoia, MC ;
Colato, S ;
Pochetti, P ;
Braschi, A ;
Pozzi, E ;
Cerveri, I .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (04) :526-531
[2]   SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance [J].
Borsani, G ;
Bassi, MT ;
Sperandeo, MP ;
De Grandi, A ;
Buoninconti, A ;
Riboni, M ;
Manzoni, M ;
Incerti, B ;
Pepe, A ;
Andria, G ;
Ballabio, A ;
Sebastio, G .
NATURE GENETICS, 1999, 21 (03) :297-301
[3]  
de Blic Jacques, 2004, Paediatr Respir Rev, V5, P316
[4]   ROLE OF HEMATOLOGICAL, PULMONARY AND RENAL COMPLICATIONS IN THE LONG-TERM PROGNOSIS OF PATIENTS WITH LYSINURIC PROTEIN INTOLERANCE [J].
DIROCCO, M ;
GARIBOTTO, G ;
ROSSI, GA ;
CARUSO, U ;
TACCONE, A ;
PICCO, P ;
BORRONE, C .
EUROPEAN JOURNAL OF PEDIATRICS, 1993, 152 (05) :437-440
[5]   COEXISTING ENDOGENOUS LIPOID PNEUMONIA, CHOLESTEROL GRANULOMAS, AND PULMONARY ALVEOLAR PROTEINOSIS IN A PEDIATRIC POPULATION - A CLINICAL, RADIOGRAPHIC, AND PATHOLOGICAL CORRELATION [J].
FISHER, M ;
ROGGLI, V ;
MERTEN, D ;
MULVIHILL, D ;
SPOCK, A .
PEDIATRIC PATHOLOGY, 1992, 12 (03) :365-383
[6]   LYSINURIC PROTEIN INTOLERANCE WITH CHRONIC INTERSTITIAL LUNG-DISEASE AND PULMONARY CHOLESTEROL GRANULOMAS AT ONSET [J].
KEREM, E ;
ELPELG, ON ;
SHALEV, RS ;
ROSENMAN, E ;
BARZIV, Y ;
BRANSKI, D .
JOURNAL OF PEDIATRICS, 1993, 123 (02) :275-278
[7]   Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor [J].
Kitamura, T ;
Tanaka, N ;
Watanabe, J ;
Uchida, K ;
Kanegasaki, S ;
Yamada, Y ;
Nakata, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (06) :875-880
[8]   Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis [J].
Latzin, P ;
Tredano, M ;
Wüst, Y ;
de Blic, J ;
Nicolai, T ;
Bewig, B ;
Stanzel, F ;
Köhler, D ;
Bahuau, M ;
Griese, M .
THORAX, 2005, 60 (01) :39-44
[9]   Increased NO production in lysinuric protein intolerance [J].
Mannucci, L ;
Emma, F ;
Markert, M ;
Bachmann, C ;
Boulat, O ;
Carrozzo, R ;
Rizzoni, G ;
Dionisi-Vici, C .
JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 (02) :123-129
[10]   Necropsy findings in lysinuric protein intolerance [J].
McManus, DT ;
Moore, R ;
Hill, CM ;
Rodgers, C ;
Carson, DJ ;
Love, AHG .
JOURNAL OF CLINICAL PATHOLOGY, 1996, 49 (04) :345-347